Department of Physiology, University of Pittsburgh, Pittsburgh. Pennsylvania 15261, USA.
J Neuroendocrinol. 1992 Apr;4(2):161-6. doi: 10.1111/j.1365-2826.1992.tb00154.x.
The proto-oncogene product of the c-fos gene, cFos, is a useful marker for luteinizing hormone-releasing hormone (LHRH) neuronal activation. While recent data indicate that in the rat, an LHRH surge plays an active role in stimulating the proestrous luteinizing hormone (LH) surge, the mechanics of the LHRH surge remain unknown. The aim of this study was to determine whether LHRH neuronal activation occurs entirely at the beginning of the LH surge or whether the number of LHRH neurons activated increases during the ascending phase of the surge. To accomplish this aim, we determined the relationship between the number of LHRH neurons expressing cFos and LH concentrations during the ascending limb of the proestrous LH surge. During the estrous cycle in the rat, on the afternoon of proestrus, the number of LHRH neurons expressing cFos increased as plasma LH levels increased to reach peak concentrations. The regression line describing these two variables had a very highly significant correlation coefficient, indicating a linear relationship. Treatment with RU486 to block progesterone's action on the afternoon of proestrus significantly reduced both the number of LHRH neurons expressing cFos and the magnitude of LH secretion during the entire ascending phase of the LH surge. An analysis of covariance with comparison of regression lines from untreated and RU486-treated animals revealed that while both sets of data established significant linear relationships between the degree of activation of LHRH neurons and plasma LH values, the slopes of the two lines were different (P = 0.031) with no statistical difference in the two intercepts. These data, together with the demonstration of an overall reduction of cFos intensity following removal of progesterone's actions, suggest progesterone alters the dynamics of LHRH neuronal activation by significantly reducing the recruitment of LHRH neurons and suppressing the level of activation of individual LHRH neurons. The results of our study support the hypothesis that the ascending phase of the LH surge results from the gradual recruitment of LHRH neurons into the active state.
c-fos 基因的原癌基因产物 cFos 是促黄体激素释放激素 (LHRH) 神经元激活的有用标志物。虽然最近的数据表明,在大鼠中,LHRH 激增在刺激发情前黄体生成素 (LH) 激增中发挥积极作用,但 LHRH 激增的机制尚不清楚。本研究的目的是确定 LHRH 神经元的激活是否完全发生在 LH 激增的开始,还是在激增的上升阶段激活的 LHRH 神经元数量增加。为了实现这一目标,我们确定了发情前 LH 激增上升阶段表达 cFos 的 LHRH 神经元数量与 LH 浓度之间的关系。在大鼠发情周期中,发情前下午,随着血浆 LH 水平升高至峰值,表达 cFos 的 LHRH 神经元数量增加。描述这两个变量的回归线具有非常高的显著相关系数,表明存在线性关系。在发情前下午用 RU486 阻断孕激素对 LHRH 神经元的作用显著降低了表达 cFos 的 LHRH 神经元数量和整个 LH 激增上升阶段的 LH 分泌量。对未处理和 RU486 处理动物的回归线进行协方差分析比较表明,尽管两组数据在 LHRH 神经元激活程度和血浆 LH 值之间建立了显著的线性关系,但两条线的斜率不同(P = 0.031),两个截距无统计学差异。这些数据,加上孕激素作用去除后 cFos 强度总体降低的证明,表明孕激素通过显著减少 LHRH 神经元的募集和抑制单个 LHRH 神经元的激活水平来改变 LHRH 神经元激活的动力学。我们的研究结果支持这样的假设,即 LH 激增的上升阶段是由于 LHRH 神经元逐渐被募集到活跃状态。